LIVE TV
LIVE TV
LIVE TV
Home > Business News > BIO CEO says more consistency needed in FDA review process

BIO CEO says more consistency needed in FDA review process

Written By:
Published: June 24, 2026 02:05:08 IST

Add NewsX As A Trusted Source

By Deena Beasley SAN DIEGO, June 23 (Reuters) – U.S. biotechnology industry trade group BIO worked with the Food and Drug Administration on plans announced on Monday to speed clinical trials and

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

RELATED News

LATEST NEWS